The development and evaluation of an attenuated measles virus vaccine.
作者信息
KATZ S L, ENDERS J F, HOLLOWAY A
出版信息
Am J Public Health Nations Health. 1962 Feb;52(2)Suppl(Suppl 2):5-10. doi: 10.2105/ajph.52.suppl_2.5.
Abstract
摘要
相似文献
1
The development and evaluation of an attenuated measles virus vaccine.
Am J Public Health Nations Health. 1962 Feb;52(2)Suppl(Suppl 2):5-10. doi: 10.2105/ajph.52.suppl_2.5.
2
3
Studies of live attenuated measles virus vaccine in man. II. Appraisal of efficacy.
Am J Public Health Nations Health. 1962 Feb;52(2)Suppl(Suppl 2):44-56. doi: 10.2105/ajph.52.suppl_2.44.
4
Studies of live attenuated measles virus vaccine in man. I. Clinical aspects.
Am J Public Health Nations Health. 1962 Feb;52(2)Suppl(Suppl 2):29-43. doi: 10.2105/ajph.52.suppl_2.29.
5
[Measles vaccination. Israeli studies with live attenuated measles virus vaccine and gamma globulin].
Harefuah. 1962 Sep 2;63:161-6.
6
Clinical and immunological studies on a live attenuated measles virus vaccine in infants and children.
Acta Paediatr (Stockh). 1962 Jul;51:401-8. doi: 10.1111/j.1651-2227.1962.tb06562.x.
7
Inactivated measles virus vaccine. II. Prevention of natural and experimental measles with the vaccine.
JAMA. 1962 Feb 10;179:391-7. doi: 10.1001/jama.1962.03050060001001.
8
Inactivated measles virus vaccine. III. A field trial in young school children.
JAMA. 1962 Feb 10;179:398-403. doi: 10.1001/jama.1962.03050060008002.
9
Administration of Enders' live measles virus vaccine with human immune globulin.
JAMA. 1962 Jun 30;180:1086-94. doi: 10.1001/jama.1962.03050260008002.
10
Studies on an attenuated measles-virus vaccine. VIII. General summary and evaluation of the results of vaccine.
N Engl J Med. 1960 Jul 28;263:180-4. doi: 10.1056/NEJM196007282630408.
引用本文的文献
1
Acute induction of IFNα is responsible for the attenuation of the live measles vaccine.
bioRxiv. 2025 Jun 9:2025.06.09.658652. doi: 10.1101/2025.06.09.658652.
2
What's going on with measles?
J Virol. 2024 Aug 20;98(8):e0075824. doi: 10.1128/jvi.00758-24. Epub 2024 Jul 23.
3
Finally neutralizing the threat? A novel SARS-CoV-2 vaccine platform that elicits enhanced neutralizing antibody responses.
mBio. 2024 Apr 10;15(4):e0006724. doi: 10.1128/mbio.00067-24. Epub 2024 Feb 26.
4
Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity.
mBio. 2024 Feb 14;15(2):e0292823. doi: 10.1128/mbio.02928-23. Epub 2024 Jan 9.
5
Seroprevalence of Measles Antibodies in the Population of the Olomouc Region, Czech Republic-Comparison of the Results of Four Laboratories.
Vaccines (Basel). 2022 Jan 25;10(2):185. doi: 10.3390/vaccines10020185.
6
A durable protective immune response to wild-type measles virus infection of macaques is due to viral replication and spread in lymphoid tissues.
Sci Transl Med. 2020 Apr 1;12(537). doi: 10.1126/scitranslmed.aax7799.
7
Oncolytic Measles Virotherapy and Opposition to Measles Vaccination.
Mayo Clin Proc. 2019 Sep;94(9):1834-1839. doi: 10.1016/j.mayocp.2019.05.006. Epub 2019 Jun 22.
8
Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity.
J Clin Immunol. 2019 May;39(4):376-390. doi: 10.1007/s10875-019-00642-3. Epub 2019 May 23.
9
Measles Vaccine.
Viral Immunol. 2018 Mar;31(2):86-95. doi: 10.1089/vim.2017.0143. Epub 2017 Dec 19.
10
Measles virus.
Hum Vaccin Immunother. 2015;11(1):21-6. doi: 10.4161/hv.34298. Epub 2014 Nov 1.
本文引用的文献
1
Studies on an attenuated measles-virus vaccine. VIII. General summary and evaluation of the results of vaccine.
N Engl J Med. 1960 Jul 28;263:180-4. doi: 10.1056/NEJM196007282630408.
2
Clinical and immunological response to live tissue culture vaccine against measles.
Acta Virol. 1960 Jul;4:201-4.
3
Studies on an attenuated measles-virus vaccine. I. Development and preparations of the vaccine: technics for assay of effects of vaccination.
N Engl J Med. 1960 Jul 28;263:153-9. doi: 10.1056/NEJM196007282630401.
4
Serological epidemiology in measles.
Yale J Biol Med. 1959 Sep;32(1):44-50.
5
6
Cultivation of measles virus in human amnion cells and in developing chick embryo.
Proc Soc Exp Biol Med. 1957 May;95(1):120-7. doi: 10.3181/00379727-95-23140.
7
[Experimental data and observations on allantois-tissue vaccine against measles].
Vopr Virusol. 1956 Mar-Apr;1(2):47-51.
8
Propagation in tissue cultures of cytopathogenic agents from patients with measles.
Proc Soc Exp Biol Med. 1954 Jun;86(2):277-86. doi: 10.3181/00379727-86-21073.
Zotero 插件